From: Tea consumption and risk of lung diseases: a two‑sample Mendelian randomization study
outcome | Pleiotropy p-value | Heterogeneity p-value | ||
---|---|---|---|---|
MR-Egger | MR-PRESSO | MR-Egger | IVW | |
IPF | 0.906 | 0.177 | 0.158 | 0.191 |
Lung cancer | 0.610 | 0.303 | 0.450 | 0.493 |
COPD | 0.532 | 0.162 | 0.170 | 0.190 |
Acute bronchitis | 0.432 | 0.150 | 0.068 | 0.072 |
Tuberculosis | 0.475 | 0.523 | 0.285 | 0.307 |
Pneumonia | 0.150 | 0.087 | 0.246 | 0.190 |